Target intelligence / Profile preview

Acetyl-CoA synthetase 2 (ACSS2)–Transcription factor EB (TFEB) metabolic axis (ACSS2–TFEB axis)

Target
ACSS2–TFEB axis
Molecular classification
Enzyme, Transcription factor
01

Overview

The Acetyl-CoA synthetase 2–Transcription factor EB (ACSS2–TFEB) metabolic axis is a critical regulatory pathway that links cellular metabolism to epigenetic control and autophagy (Li et al., Nature, 2017; Yin et al., Cell Death & Disease, 2025). Acetyl-CoA synthetase 2 (ACSS2) is an enzyme that converts acetate into acetyl-CoA, and under conditions of metabolic stress or hypoxia, it translocates to the nucleus (Li et al., Nature, 2017; NIH, 2022). In the nucleus, ACSS2 forms a complex with Transcription Factor EB (TFEB), the master regulator of the autophagy-lysosome pathway, and provides a local supply of acetyl-CoA for histone acetylation at the promoters of TFEB target genes (Li et al., Nature, 2017; Yin et al., Cell Death & Disease, 2025). This axis is frequently hijacked by cancer cells, such as those in glioblastoma and breast cancer, to survive in nutrient-poor microenvironments by maintaining autophagic flux (NIH, 2022; Miller et al., 2021). Targeting this axis, primarily through ACSS2 inhibitors like MTB-9655, offers a strategy to disrupt cancer cell energy homeostasis and sensitize tumors to other therapies (ASCO, 2022; NCI, 2022). Beyond oncology, the axis is also implicated in neurodegenerative and metabolic diseases where autophagy and lipid metabolism are dysregulated (NIH, 2025; Yin et al., Cell Death & Disease, 2025). Potential safety concerns include the disruption of basal autophagy in normal tissues and organ-specific metabolic dysregulation, although ACSS2 inhibition has shown a favorable safety profile in early clinical studies (ASCO, 2022; NIH, 2025).

Other names
ACSS2-TFEB signaling pathwayACSS2-TFEB regulatory axisACSS2-TFEB autophagy axisAMPK-ACSS2-TFEB pathway
02

Mechanism of action

Inhibition of ACSS2-mediated nuclear acetyl-CoA production, which reduces histone acetylation at TFEB-target gene promoters, thereby suppressing the expression of autophagy and lysosomal genes and inducing metabolic stress in cancer cells.

03

Biological functions

AutophagyLysosomal biogenesisHistone acetylationMetabolic reprogrammingCell survival
04

Disease associations

CancerGlioblastomaBreast cancerHead and neck squamous cell carcinomaNeurodegenerative diseaseMetabolic disorder
05

Safety considerations

Potential disruption of basal autophagy in normal tissuesOrgan-specific metabolic dysregulationOff-target UGT1A1 inhibitionContext-dependent role in tumor progression
06

Interacting drugs

MTB-9655

3 more in the full profile.

07

Biomarkers

ACSS2 expressionACSS2 phosphorylation at Ser659Nuclear ACSS2 localization11C-acetate PET imaging

Beyond the preview

Go deeper on Acetyl-CoA synthetase 2 (ACSS2)–Transcription factor EB (TFEB) metabolic axis (ACSS2–TFEB axis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetyl-CoA synthetase 2 (ACSS2)–Transcription factor EB (TFEB) metabolic axis (ACSS2–TFEB axis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call